Close Menu

NEW YORK – Danaher today reported a 4 percent year-over-year increase in its second quarter revenues, which included a 6 percent rise in life sciences segment revenues and a rise of almost 5 percent in its diagnostics segment.

For the three months ended June 28, total revenues reached $5.16 billion, up from $4.98 billion a year ago. It beat the consensus Wall Street estimate of $5.08 billion. Core revenue growth was about 6 percent, the Washington, DC-based conglomerate said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.